Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Apr 21:12:e35865.
doi: 10.2196/35865.

The Pharmacoeconomic Impact of Pharmaceutical Care in the Hospital: Protocol for an Overview of Systematic Reviews

Fábio Jorge Ramalho de Amorim #  1 , Fernanda Valença-Feitosa #  1 , Marcos Cardoso Rios #  1 , Carlos Adriano Santos Souza #  2 , Izadora Menezes da Cunha Barros #  3 , Alfredo Dias de Oliveira-Filho #  1 , Divaldo Pereira de Lyra-Júnior #  1
Affiliations

The Pharmacoeconomic Impact of Pharmaceutical Care in the Hospital: Protocol for an Overview of Systematic Reviews

Fábio Jorge Ramalho de Amorim et al. JMIR Res Protoc. .

Abstract

Background: The clinical activities developed by pharmacists in a hospital environment can improve health outcomes and generate savings for hospitals. However, to determine whether pharmaceutical interventions are cost effective, it is essential to define a method according to which cost-effectiveness is intended to be measured. In addition, the quality of economic assessments and the amount of information present in systematic reviews in the literature make it difficult to analyze the effects of this intervention.

Objective: This paper aims to provide an overview of systematic reviews on the pharmacoeconomic impact of the performance of pharmaceutical care in hospitals.

Methods: A systematic search of the Cochrane Library databases, PubMed or MEDLINE, LILACS, Scopus, Web of Science, Google Scholar, and Open Thesis will be performed using the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) statement. The search will involve the use of keywords determined using the Medical Subject Headings database to define the search terms and include the following terms: "pharmacoeconomics," "pharmaceutical care," and "hospital." The study designs to be included will be systematic reviews of good quality. Studies will be included that address pharmacoeconomics; studies that evaluated pharmaceutical care in hospitals; and studies published in Portuguese, English, or Spanish. The primary outcome sought in the systematic reviews will be the cost ratio in monetary units and the outcomes in monetary or natural units. The secondary economic outcomes considered will be determined based on factors associated with the drugs and translated into benefit, efficacy, or utility.

Results: It is intended to start this overview in January 2023. Thus far, only previous searches have been carried out to contextualize the theme and build the protocol.

Conclusions: This overview will determine the pharmacoeconomic impact of pharmaceutical care interventions in the hospital environment. In addition, this study will point out which clinical outcomes in natural units are impacted by the performance of pharmaceutical care and the strengths and limitations of each approach. It will also identify gaps in the literature and areas for future work.

Trial registration: PROSPERO CRD42019140665; https://tinyurl.com/bddwnz43.

Keywords: cost benefit; cost-effectiveness; cost-utility; hospital; overview; pharmaceutical care; pharmacoeconomics.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: None declared.

References

    1. Gammie T, Vogler S, Babar Z. Economic Evaluation of Hospital and Community Pharmacy Services. Ann Pharmacother. 2017 Jan;51(1):54–65. doi: 10.1177/1060028016667741.1060028016667741 - DOI - PubMed
    1. Correr CJ, Pontarolo R, Melchiors AC, Paula e Souza RA, Rossignoli P, Fernández-Llimós F. [Patient satisfaction with pharmacy services: translation and validation of the Pharmacy Services Questionnaire for Brazil] Cad Saude Publica. 2009 Jan;25(1):87–96. doi: 10.1590/s0102-311x2009000100009. https://www.scielo.br/scielo.php?script=sci_arttext&pid=S0102-311X200900... S0102-311X2009000100009 - DOI - PubMed
    1. Lyra JD, Amaral R, Abriata J, Pelá I. Satisfacción como resultado de un programa de atención farmacéutica para pacientes ancianos en Ribeirão Preto ? São Paulo (Brasil) Seguimiento Farmacoterapéutico. 2005;3(1):30–42.
    1. Haby HE, Alm RA, Corona AR, Hall AC. Population health model for pharmacist assessment and independent prescribing of statins in an ambulatory care setting. J Am Pharm Assoc (2003) 2020 Jan;60(1):130–137. doi: 10.1016/j.japh.2019.08.003.S1544-3191(19)30397-8 - DOI - PubMed
    1. Mitterer S, Zimmermann K, Bergsträsser E, Simon M, Gerber A, Fink G. Measuring Financial Burden in Families of Children Living With Life-Limiting Conditions: A Scoping Review of Cost Indicators and Outcome Measures. Value Health. 2021 Sep;24(9):1377–1389. doi: 10.1016/j.jval.2021.03.015. https://linkinghub.elsevier.com/retrieve/pii/S1098-3015(21)01491-1 S1098-3015(21)01491-1 - DOI - PubMed

LinkOut - more resources